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Objective: The prognosis of patients with glioblastoma remains poor even after various treatments such
as surgery, radiotherapy, and chemotherapy. Thus, development of new drugs is urgently needed. The
mechanisms underlying the cytotoxicity of caffeine in glioma cells are not clearly understood. This study
aimed to assess the activities of histone deacetylase 1 (HDAC1) and histone acetyltransferase (p300) in
RT2 glioma cells treated with caffeine.
Materials and Methods: Cell viability and activity of HDAC1 and p300 in RT2 glioma cells were assayed
after treatment with caffeine for 48 hours.
Results: Cell viability decreased signiﬁcantly after treatment with 0.5mM, 1mM, and 2mM caffeine.
HDAC1 protein activity decreased signiﬁcantly with various concentrations of caffeine, whereas the
activity of p300 increased signiﬁcantly. In addition, the viability of RT2 cells remained high, but HDAC1
activity decreased, and p300 activity increased markedly with 0.5mM caffeine treatment. We used
microRNA and small interfering RNA (siRNA) to regulate HDAC1 and p300 to further understand the
impact on glioblastomas. siRNA downregulated p300 and thus increased the viability of RT2 cells,
therefore, caffeine combined with siRNA abolished the efﬁcacy of caffeine, which conﬁrmed that caffeine
upregulated p300 and reduced cell viability. We also found increased HDAC1 activity when RT2 cells
were treated with a combination of caffeine and miR-449a and thus increased the viability of RT2 cells.
Conclusion: Our data suggest that a new strategy, caffeine, could increase glioma cell death by decreasing
HDAC1 activity and/or by increasing p300 activity. The changes in HDAC1 and p300 activities appeared to
occur earlier than loss of RT2 cells.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Malignant glioma is the most common primary brain tumor in
adults. The poor prognosis of malignant glioma is largely due to a
highly deregulated tumor genome with opportunistic deletion of
tumor suppressor genes, ampliﬁcation and/or mutational hyper-
activation of receptor tyrosine kinase, and defects in thelogy, Dalin Tzu Chi Hospital,
Road, Dalin, Chiayi, Taiwan.
ang).
lief Tzu Chi Foundation. Publishedapoptosis signaling machinery [1]. In addition, abnormal
expression of speciﬁc genes is associated with malignant glioma
[2e5].
Epidemiological studies have also shown that consumption of
caffeinated beverages, including coffee and tea, may reduce the risk
of adult glioma [6,7]. In vitro, caffeine (2mM) enhances the cyto-
toxicity of cisplatin and camptothecin in human U251 glioma cell
lines [8]. Caffeine blocks glioblastoma invasion and extended sur-
vival [9] and increased caspase-dependent apoptosis of glioma cells
[10]. Our previous studies showed that tetrandrine and caffeine
(0.5mM and 1mM) could induce glioma cell death [11]. Caffeine
reduces glioma cell proliferation through G0/G1-phase cell cycle
arrest by suppressing retinoblastoma protein phosphorylation [10].
Caffeine can attenuate G2 delay and enhance the cytotoxicity ofby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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Caffeine can inhibit some kinase activities, including various forms
of mechanistic target of rapamycin and phosphoinositide 3-kinase
(PI3K) in tumor cells [12]. Also, caffeine can increase phosphatase
and tensin homolog (PTEN) expression, leading to PI3Keprotein
kinase B (Akt) pathway inactivation, and blocking of osteosarcoma
cell proliferation [13]. Caffeine confers radiosensitization of PTEN-
deﬁcient malignant glioma cells by enhancing ionizing-radiation-
induced G1 arrest and negatively regulating Akt phosphorylation
[14].
Histone deacetylases (HDACs) and histone acetyltransferases
(HATs) are involved in determining the state of acetylation of
histones, which are the early steps for genetic transcription [2].
There are reports that altered activities of HDACs and HATs are
associated with cancer formation. For example, overexpression of
HDAC1 is associated with human gastric and prostate cancers, and
with malignant glioma [3]. The antiproliferative effect of HDAC
inhibitors is mediated by G0/G1 cell cycle arrest [15]. HDAC in-
hibitor activates p53 transcription and acetylation promotes
upregulated modulator of apoptosis to catalyze the mitochondrial
pathway to induce growth inhibition, cell cycle arrest, and
apoptosis [16]. Thus, HDAC1 has recently been recognized as a
promising target for cancer therapy, including treatment of ma-
lignant glioma. In addition, decreased expression of HATs is
associated with several diseases, such as cardiac hypertrophy,
asthma and cancer [4]. Loss of heterozygosity of the HAT p300 was
found in 80% of malignant gliomas [5]. Loss of microRNA (miR)-
449a, an endogenous HDAC-1 inhibitor, may promote abnormal
performance of HDAC-1 in prostate cancer, contributing to the
cause of the disease [17]. The effects of caffeine on the activity of
HDACs and HATs in glioma cells are still unknown. The detailed
effects and mechanisms underlying caffeine-induced cytotoxicity
in glioma cells remain unclear.
In this study, we investigated the effects of caffeine on the
viability of malignant glioma cells and the activities of HDAC1 and
p300. We hypothesized that caffeine could increase death of RT2
glioma cells by decreasing HDAC1 activity and increasing p300
activity.2. Materials and methods
2.1. Cell line
RT2 cells were derived from an avian-sarcoma-virus-induced
brain tumor in a Fischer 344 rat. This cell line was provided by
National Taiwan University Hospital [18], and was maintained in
Dulbecco's Modiﬁed Eagle's Medium supplemented with 10% fetal
bovine serum, 2mM L-glutamate and 100 U/mL penicillin at 37C in
a humidiﬁed incubator with a 5% CO2 atmosphere.2.2. siRNA and microRNA transfection
Control small interfering RNA (siRNA) (Thermo Scientiﬁc
siGLO siGENOME, and ON-TARGETplus Control Reagents), siRNA
against p300 (Thermo Scientiﬁc Dharmacon siGENOME and ON-
TARGETplus siRNA Reagents), microRNA (miRNA) mimic and miR-
449a (miRNA for HDAC1, Thermo Scientiﬁc miRIDIAN microRNA
Mimics, Hairpin Inhibitors and Negative Controls) were obtained
from Dharmacon (Franklin Lakes, NJ, USA). Cells (1  104) were
seeded on 12-well plates the day before transfection. The me-
dium was switched to Dulbecco's Modiﬁed Eagle's Medium and
either control siRNA or anti-p300 siRNA in Oligofectamine was
added to the culture medium for 48 hours (ﬁnal concentration
25 nmol/L).2.3. Cell viability assay
Cell viability was measured 48 hours after treatment with
various concentrations of caffeine (0mM, 0.5mM, 1mM, and 2mM)
by a colorimetric assay for 96-well plates using 2-(4-iodophenyl)-
3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium mono-
sodium salt (WST-1; Clontech, Palo Alto, CA, USA). Each plate
contained blanks, controls, and treatment groups. Treatment con-
sisted of addition of 10 mL of premixed WST-1 cell proliferation
reagent to each well (1:10 ﬁnal dilution).
The plate was incubated for 4 hours at 37C in a humidiﬁed
atmosphere maintained at 5% CO2. Absorbance at 450 nm (refer-
ence wavelength 690 nm) was measured using a multiwell plate
reader (Anthos Zenyth 3100 Microplate Multimode Detector;
Salzburg, Austria).
2.4. HDAC1 activity assay
Assays were performed using the enzyme-linked immunosor-
bent assay kit for HDAC1 (USCN Life Science,Wuhan, China). Brieﬂy,
100 mL of cells or standards were added to each well and incubated
for 2 hours at 37C. Then, the liquid was removed from each well.
We added 100 mL Detection Reagent A to each well and incubated
for 1 hour at 37C. The liquid was removed from each well and the
wells were washed with wash solution three times. Detection Re-
agent B (100 mL) was added to the wells and incubated for 30 mi-
nutes at 37C. The liquid was removed from each well and the wells
were washed with wash solution ﬁve times. Substrate solution
(90 mL) was added followed by incubation for 20 minutes at 37C.
Stop solution (50 mL) was added and the plates were read on a
multiwell plate reader at 450 nm. HDAC1 activity was expressed as
the relative optical density (OD) values per nanogram of protein
sample.
2.5. HAT (p300) activity assay
Assayswere performed using the HATactivity colorimetric assay
(BioVision Research Products, Mountain View, CA, USA). Brieﬂy,
50 mg puriﬁed proteins from cells were diluted in 40 mL deionized
distilled water; 68 mL assay mix was added followed by incubation
at 37C for 1e4 hours. Samples were read in an enzyme-linked
immunosorbent assay plate reader at 440 nm. HAT (p300) activ-
ity was expressed as relative OD values per microgram of protein
sample.
2.6. Statistical analysis
The data are presented as the mean ± standard deviation, unless
indicated otherwise. The expression levels of HDAC1 or p300 were
compared separately among all groups by one-way analysis of
variance with post hoc Bonferroni correction. All analyses were
performed by commercial software (Stata Corp LP, College Station,
TX, USA), and p values < 0.05 were considered statistically signiﬁ-
cant. Data are representative of three independent experiments
(error bars, standard deviation of triplicate samples).
3. Results
Fig. 1 shows the effects of various concentrations of caffeine
(0mM, 0.5mM, 1mM, and 2mM) on the viability of RT2 glioma cells
at 48 hours. Compared with the control group without caffeine
treatment (100%), the viability decreased signiﬁcantly when RT2
cells were treated with 0.5mM (67.3 ± 1.16%), 1mM (54.5 ± 2.53%),
or 2mM (10.3 ± 1.08) caffeine (p < 0.0001 vs. control group).
Fig. 1. Effects of caffeine on the viability of RT2 glioma cells at 48 hours. Compared
with the control group without caffeine treatment (100%), viability decreased signiﬁ-
cantly when RT2 cells were treated with 0.5mM or more caffeine. *p < 0.0001 versus
control group.
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caffeine combined with miR-449a on the viability of RT2 glioma
cells at 48 hours. Comparedwith the negative control group (100%),
the viability was unchanged when cells were treated with miR-
449a (99.3 ± 1.56%) only. miRNA did not affect RT2 cell growth. In
contrast, the caffeine-decreased viability effect was abolishedwhen
RT2 cells were treated with a combination of miRNA and 0.5mM
(82.9 ± 2.45%), 1mM (63.6 ± 1.15%), or 2mM (25.5 ± 1.95%) caffeine
(p < 0.0001 vs. caffeine only).
Fig. 3 shows the effects of various concentrations of caffeine or
caffeine combined with p300 siRNA on the viability of RT2 glioma
cells at 48 hours. Comparedwith the negative control group (100%),
the viability was unchanged when cells were treated with siRNA
(107.3 ± 3.07%) only. siRNA did not affect RT2 cell growth. In
contrast, the caffeine-decreased viability effect was abolishedwhen
RT2 cells were treated with a combination of siRNA and 0.5mM
(96.4 ± 2.95%), 1mM (59.7 ± 2.02%) or 2mM (23.6 ± 1.36%) caffeine
(p < 0.0001 vs. caffeine only).
Fig. 4 shows the effects of various concentrations of caffeine or
caffeine combined with miR-449a on the activity of HDAC1 in RT2Fig. 2. RT2 cells transfected with miR-449a and treated with caffeine at 48 hours. Compared
were treated with 0.5mM, 1mM, or 2mM caffeine. In contrast, the caffeine-decreased viabil
and caffeine. *p < 0.0001 versus control group, **p < 0.0001 versus caffeine only. miRNA ¼glioma cells at 48 hours. Compared with the negative control group
(1.17 ± 0.11 ng/mL), the activity of HDAC1 showed no signiﬁcant
changes when RT2 cells were treated with miR-449a
(1.04 ± 0.15 ng/mL) only. The activity of HDAC1 decreased signiﬁ-
cantly when RT-2 cells were treated with 0.5mM (0.43 ± 0.20 ng/
mL), 1mM (0.39 ± 0.19 ng/mL) or 2mM (0.20 ± 0.02 ng/mL) caffeine
(p < 0.0001vs. control group). Activity of HDAC1 increased signiﬁ-
cantly when cells were treated with a combination of miRNA-449a
and 0.5mM (1.06 ± 0.25 ng/mL), 1mM (0.86 ± 0.23 ng/mL) or 2mM
(0.5 ± 0.02 ng/mL) caffeine (p < 0.0001 vs. caffeine only).
Fig. 5 shows the effects of various concentrations of caffeine or
caffeine combined with siRNA on the activity of p300 in RT2 glioma
cells at 48 hours. Compared with the negative control group
(0.45 ± 0.03, OD 440 nm), the activity of p300 showed no signiﬁ-
cant changes when RT2 cells were treated with siRNA (0.44 ± 0.04,
OD 440 nm) only. The activity of p300 increased signiﬁcantly when
RT-2 cells were treated 0.5mM (0.70 ± 0.05, OD 440 nm), 1mM
(0.78 ± 0.06, OD 440 nm) or 2mM (0.76 ± 0.06, OD 440 nm) caffeine
(p < 0.0004 vs. control group). Furthermore, the activity of p300
decreased signiﬁcantly when RT2 cells were treated with a com-
bination of siRNA and 0.5mM (0.39 ± 0.01, OD 440 nm), 1mM
(0.38 ± 0.01, OD 440 nm) or 2mM (0.37 ± 0.07, OD 440 nm) caffeine.
There were no signiﬁcant differences compared with the control
group.4. Discussion
Our previous studies showed that tetrandrine and caffeine
(0.5mM and 1mM) induce glioma cell death, possibly via increasing
eukaryotic initiation factor-2a phosphorylation, decreasing cyclin-
D1 expression, and increasing the caspase-dependent and -inde-
pendent apoptosis pathways [11]. The present study showed that
caffeine increased glioma cell death, decreased HDAC1 activity, and
increased p300 activity; in addition, we found that the changes in
HDAC1 and p300 activities appeared to occur earlier than loss of
RT2 cells. In other words, the viability of RT2 cells remained high,
but HDAC1 decreased and p300 increased markedly with 0.5mM
caffeine treatment.We also found that HDAC1 activity was reversedwith the negative control group (100%), viability decreased signiﬁcantly when RT2 cells
ity effect was abolished when RT2 cells were treated with a combination of microRNA
microRNA.
Fig. 3. RT2 cells transfected with p300 siRNA to silence its expression at 48 hours. Compared with the negative control group (100%), viability decreased signiﬁcantly when RT2 cells
were treated with 0.5mM, 1mM, or 2mM caffeine. In contrast, caffeine-decreased viability effect was abolished when RT2 cells were treated with a combination of microRNA and
caffeine. *p < 0.0001 versus control group, **p < 0.0001 versus caffeine only. siRNA ¼ small interfering RNA.
Fig. 4. Effects of various concentrations of caffeine or caffeine combined with miR-449a on activity of HDAC1 in RT2 glioma cells at 48 hours. Compared with the control group
without caffeine treatment, expression of HDAC1 decreased signiﬁcantly when RT2 cells were treated with 0.5 mM or more caffeine. The activity of HDAC1 increased signiﬁcantly
when RT2 cells were treated with a combination of miR-449a and various concentrations of caffeine. *p < 0.0001 versus control group, **p < 0.0001 versus caffeine only.
HDAC ¼ histone deacetylase; miRNA ¼ microRNA.
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miR-449a.
Both HDACs and HATs are involved in many physiological and
pathological processes by the modulation of transcription of many
genes. HDAC1 is a predominantly nuclear protein with ubiquitous
expression; it is induced upon growth factor activation and is
increased in highly proliferative tissues, embryonic stem cells,
several transformed cell lines, and in the majority of cancers
[19,20]. Consistent with this, HDAC inhibitors might induce p53-
dependent and p53-independent Bax-mediated neuronal
apoptosis [21]. HDAC inhibitor is associated with improved overalland progression-free survival in glioblastoma but worse outcomes
in Grade II/III gliomas treated with temozolomide [22].
HATs are also essential for cell proliferation, differentiation, and
apoptosis [23]. Decreased expression or mutations of HATs are
associated with several types of cancer [4,5]. Previous studies
showed that mitogen-activated protein kinases phosphorylate
several types of HATs and directly increase their enzymatic activ-
ities [24,25], or regulate their activity indirectly by modifying
signaling pathways affecting HAT activity [26,27].
Imbalanced or altered expression or activities of HDACs and
HATs are associated with cancer formation. Previous reports reveal
Fig. 5. Effects of various concentrations of caffeine or caffeine combined with siRNA on the activity of p300 in RT2 glioma cells at 48 hours. Compared with the control group
without caffeine treatment, expression of p300 increased signiﬁcantly when RT2 cells were treated with 0.5 mM or more caffeine. Activity of p300 decreased signiﬁcantly when RT2
cells were treated with a combination of siRNA and various concentrations of caffeine. *p < 0.0004 versus control group. siRNA ¼ small interfering RNA.
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[3], whereas loss of heterozygosity of the HAT p300 was found in
80% of malignant gliomas [5]. In this study, we found that caffeine
modulated the imbalance of HDAC1 and p300 in RT2 cells by
decreasing HDAC1 activity and increasing p300 activity. These ef-
fects might account for caffeine-induced cytotoxicity of RT2 cells.
In conclusion, our data suggest that a new strategy, caffeine,
could increase glioma cell death; possibly by decreasing HDAC1
activity and/or increasing p300 activity. In addition to traditional
chemotherapy, caffeine might be added as a complementary
treatment for human gliomas in the future. Further clinical trials
are warranted to document this cell study.Acknowledgments
This work was supported by a grant from Buddhist Dalin Tzu Chi
General Hospital (DTCRD100(2)-I-06) in Chiayi, Taiwan.References
[1] Krakstad C, Chekenya M. Survival signaling and apoptosis resistance in glio-
blastomas: opportunities for targeted therapeutics. Mol Cancer 2010;9:135.
[2] Santer FR, H€oschele PP, Oh SJ, Erb HH, Bouchal J, Cavarretta IT, et al. Inhibition
of the acetyltransferases p300 and CBP reveals a targetable function for p300
in the survival and invasion pathways of prostate cancer cell lines. Mol Cancer
Ther 2011;10:1644e55.
[3] Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of
differentiation or apoptosis of transformed cells. J Nat Cancer Inst 2000;15:
1210e6.
[4] Choi KC, Park S, Lim BJ, Sung AR, Lee YH, Shiota M, et al. Procyanidin B3, an
inhibitor of histone acetyltransferase, enhances the action of antagonist for
prostate cancer cells via inhibition of p300-dependent acetylation of androgen
receptor. Biochem J 2011;433:235e44.
[5] Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB,
Ranga U, et al. Curcumin, a novel p300/CREB-binding protein-speciﬁc inhib-
itor of acetyltransferase, represses the acetylation of histone/nonhistone
proteins and histone acetyltransferase-dependent chromatin transcription.
J Biol Chem 2004;49:51163e71.
[6] Holick CN, Smith SG, Giovannucci E, Michaud DS. Coffee, tea, caffeine intake,
and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol
Biomarkers Prev 2010;19:39e47.[7] Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, et al.
Coffee and tea intake and risk of brain tumors in the European Prospective
Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr
2010;92:1145e50.
[8] Janss AJ, Levow C, Bernhard EJ, Muschel RJ, McKenna WG, Sutton L, et al.
Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camp-
tothecin in human brain tumor cell lines. Exp Cell Res 1998;243:29e38.
[9] Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, et al. Caffeine-mediated
inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor
subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res
2010;70:1173e83.
[10] Ku BM, Lee YK, Jeong JY, Ryu J, Choi J, Kim JS, et al. Caffeine inhibits cell
proliferation and regulates PKA/GSK3b pathways in U87MG human glioma
cells. Mol Cells 2011;31:275e9.
[11] Chen JC, Hwang JH, Chiu WH, Chan YC. Tetrandrine and caffeine modulated
cell cycle and increased glioma cell death via caspase-dependent and caspase-
independent apoptosis pathways. Nutr Cancer 2014;66:700e6.
[12] Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y, et al. Crosstalk
between the PI3K/mTOR and MEK/ERK pathways involved in the mainte-
nance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
Stem cells 2010;28:1930e9.
[13] Bennani-Baiti IM. Epigenetic and epigenomic mechanisms shape sarcoma and
other mesenchymal tumor pathogenesis. Epigenomics 2011;3:715e32.
[14] Sinn B, Tallen G, Schroeder G, Grassl B, Schulze J, Budach V, et al. Caffeine
confers radiosensitization of PTEN-deﬁcient malignant glioma cells by
enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt
phosphorylation. Mol Cancer Ther 2010;9:480e8.
[15] Eyüpoglu IY, Hahnen E, Tr€ankle C, Savaskan NE, Siebzehnrübl FA, Buslei R,
et al. Experimental therapy of malignant gliomas using the inhibitor of his-
tone deacetylase MS-275. Mol Cancer Ther 2006;5:1248e55.
[16] Jin H, Liang L, Liu L, Deng W, Liu J. HDACs inhibitor DWP0016 activates p53
transcription and acetylation to inhibit cell growth in U251 glioblastoma cells.
J Cell Biochem 2013;114:1498e509.
[17] Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, et al. miR-449a
targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene
2009;28:1714e24.
[18] Chen Y, Tseng SH. The potential of tetrandrine against gliomas. Anticancer
Agents Med Chem 2010;10:534e42.
[19] Waltregny D, North B, Van Mellaert F, de Leval J, Verdin E, Castronovo V.
Screening of histone deacetylases (HDAC) expression in human prostate
cancer reveals distinct class I HDAC proﬁles between epithelial and stromal
cells. Eu J Histochem 2004;3:273e90.
[20] Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, et al. Role
for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol
2007;27:4784e95.
[21] Uo T, Veenstra TD, Morrison RS. Histone deacetylase inhibitors prevent p53-
dependent and p53-independent Bax-mediated neuronal apoptosis through
two distinct mechanisms. J Neurosci 2009;29:2824e32.
J.-C. Chen, J.-H. Hwang / Tzu Chi Medical Journal 28 (2016) 103e108108[22] Redjal N, Reinshagen C, Le A, Walcott BP, McDonnell E, Dietrich J, et al. Valproic
acid, compared to other antiepileptic drugs, is associated with improved overall
and progression-free survival in glioblastoma but worse outcome in grade II/III
gliomas treated with temozolomide. J Neurooncol 2016;127:505e14.
[23] Isharwal S, Miller MC, Marlow C, Makarov DV, Partin AW, Veltri RW. p300
(histone acetyltransferase) biomarker predicts prostate cancer biochemical
recurrence and correlates with changes in epithelia nuclear size and shape.
Prostate 2008;68:1097e104.
[24] Park PH, Lim RW, Shukla SD. Involvement of histone acetyltransferase (HAT)
in ethanol-induced acetylation of histone H3 in hepatocytes: potential
mechanism for gene expression. Am J Physiol Gastrointest Liver Physiol
2005;289:1124e36.[25] Kawasaki H, Schiltz L, Chiu R, Itakura K, Taira K, Nakatani Y, et al. ATF-2 has
intrinsic histone acetyltransferase activity which is modulated by phosphor-
ylation. Nature 2000;405:195e200.
[26] Koch A, Giembycz M, Ito K, Lim S, Jazrawi E, Barnes PJ, et al. Mitogen-activated
protein kinase modulation of nuclear factor-kappaB-induced granulocyte
macrophage-colony stimulating factor release from human alveolar macro-
phages. Am J Respir Cell Mol Biol 2004;30:342e9.
[27] Jun JH, Yoon WJ, Seo SB, Woo KM, Kim GS, Ryoo HM, et al. BMP2-activated
Erk/MAP Kinase stabilizes Runx2 by increasing p300 levels and histone ace-
tyltransferase activity. J Biol Chem 2010;285:36410e9.
